BioWorld - Friday, January 24, 2020

Conferences
%{topic} RSS Feed RSS

Gene therapy
Precision Medicine World Conference

AI, data science companies strut their stuff at PMWC

January 23, 2020
By Holland Johnson
No Comments
SANTA CLARA, Calif. – While many of the presentations at the Precision Medicine World Conference revolved around clinical studies and their promise for future breakthroughs in health care, a continuous stream of companies made their pitches for translating these studies into actual products that can benefit patients now.
Read More
Owen-Smith-Ireland-Genomics-1-23.png
Genomics Summit 2020

Ireland’s embrace of genomics remains tentative

January 23, 2020
By Cormac Sheridan
No Comments
DUBLIN – “Welcome to the conversation,” Abbvie Inc.’s head of genomic research, Howard Jacob, an early pioneer of genomics-driven medicine, told delegates during a keynote address at the Genomics Summit 2020 event Jan. 23. Ireland is very much a latecomer to that conversation and it has yet, as a country, to figure out what the shape of its contribution to the genomic era of medicine is going to be.
Read More
Money magnet
Precision Medicine World Conference

Novel Dx companies start to see a better path with payers, but continue to work all the angles

January 23, 2020
By Stacy Lawrence
No Comments
SANTA CLARA, Calif. – It has never been easy to get payers to reimburse in a timely and adequate fashion for novel diagnostics, making it notoriously difficult to build a business from them. But a few high-flying diagnostics companies, such as Madison, Wis.-based Exact Sciences Corp. and Redwood City, Calif.-based Guardant Health Inc., have been blazing the trail recently on how to rapidly scale up to become valuable commercial entities from origins as a research-based startup.
Read More
Cancer-and-Cancer-immunotherapy.png
Precision Medicine World Conference

Cancer genomic tests often aren’t done to guideline; germline data presents unique issues

January 23, 2020
By Stacy Lawrence
No Comments
SANTA CLARA, Calif. – Just as it does with treatments, the National Comprehensive Cancer Network (NCCN) offers detailed guidelines on genomic testing by cancer type. These are key in determining what physicians can prescribe routinely and what insurers will cover. But those guidelines aren’t followed regularly outside a major research hospital setting, thereby obviating access to tumor genetic information that could help to better guide treatment. Even if current guidelines are followed, physicians and patients can get information back from the tests that neither party is prepared to process.
Read More
Puzzle-pieces-globe.png
Precision Medicine World Conference

Verily highlights diabetes care, Project Baseline even as related partnerships are restructured

January 22, 2020
By Stacy Lawrence
No Comments
SANTA CLARA, Calif. – Diabetes seems likely to be the first area to really show concrete products and results for the ambitious Verily Life Sciences, which is the med-tech business of Mountain View, Calif.-based Google parent Alphabet Inc. However, its two major diabetes partners both have been rethinking the relationship.
Read More
1-22-founder-fund-thiel.png
Precision Medicine World Conference

Thiel calls for improving research grant, regulatory processes to enhance scientific innovation

January 22, 2020
By Stacy Lawrence
No Comments
SANTA CLARA, Calif. – Peter Thiel is not a fan of incremental science. The high-profile venture capital investor, who invests across technology and the life sciences via various vehicles, including the Founders Fund, suggested that as academic and government bureaucracies have scaled up and rigidified over the last 50 or 60 years, that has eroded the ability of researchers to pursue innovative science.
Read More

Popular Stories

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe